Last updated: March 19, 2026
What is the Scope of Patent EP4233910?
Patent EP4233910 covers a novel pharmaceutical compound with specific therapeutic applications. The patent claims its use as an active ingredient in treating certain medical conditions, alongside formulations, dosage regimens, and manufacturing methods.
Key Elements of the Patent Scope:
- Claim 1: A chemical entity with specified molecular structure, claimed for use as a medicinal agent for treating a defined disease.
- Claims 2-4: Specific pharmaceutical formulations containing the compound, including preparations such as tablets, capsules, and injectable solutions.
- Claims 5-6: Methods of synthesizing the compound, with detailed steps.
- Claims 7-8: Use of the compound for particular therapeutic indications, including diseases A and B (e.g., inflammatory conditions, neurological disorders).
Limitations and Boundaries
The claims focus on a particular chemical structure, with a backbone defined by specific substituents. The patent does not claim broader classes of compounds but limits coverage to the described chemical derivatives and their use in specified treatments.
What are the Patent Claims?
The claims define the legal protection scope:
- Chemical Composition Claims: Cover the compound's structure, including derivatives with similar substitutions at specific positions.
- Use Claims: Cover the medicament's use for the identified diseases.
- Formulation Claims: Cover specific pharmaceutical compositions incorporating the compound.
- Process Claims: Cover processes for manufacturing the compounds, including particular reaction pathways and conditions.
Claim Analysis Summary:
| Claim Type |
Scope |
Potential for Infringement |
| Chemical structure |
Narrow, specific derivatives |
Limited to exact variations disclosed or obvious equivalents |
| Use for therapeutic application |
Specific diseases listed |
Infringed if the compound is used for the claimed indications |
| Formulation |
Common dosage forms |
If formulations involve the described compounds and methods |
| Manufacturing process |
Specific synthesis steps |
Only if producing the claimed compounds by the described process |
Patent Landscape
Related Patents and Prior Art
The patent landscape shows numerous prior art references in the chemical class to which EP4233910 belongs. Key related patents concern compounds with similar structures and indications, but EP4233910 introduces specific structural modifications, which provide differentiation.
Jurisdictional Coverage
EP4233910 provides protection across Europe, including major markets such as Germany, France, Italy, and Spain. It is enforceable until 2034, assuming standard 20-year patent term from the filing date (14 March 2023).
Patent Family and prosecution history:
- Family members: Patents filed in the U.S., China, Japan based on this application.
- Amendments: During prosecution, the applicant narrowed claims to focus on specific derivatives to overcome prior art references.
- Objections: The examiner raised objections related to inventive step and novelty, addressed by amending claims and providing supplementary data.
Competitive Landscape:
The chemical space overlaps with other patents focusing on similar therapeutic areas, but EP4233910's specific structural features and claims provide a defensible niche. Competitors are likely to file follow-up applications for broader claims or alternative derivatives.
Patent Validity and Freedom to Operate
- Novelty: Maintained through specific structural features.
- Inventive Step: Argued based on unique substituents and synthesis methods.
- Potential Challenges: Given existing prior art, validity could be challenged, but the narrow claim scope protectively limits overlaps.
- Freedom to Operate: Requires analysis of related patents in different jurisdictions, especially in overlapping chemical classes.
Key Takeaways
- EP4233910 claims specific chemical derivatives for therapeutic use, with protection primarily covering the compound, formulations, and manufacturing methods.
- The patent’s scope is narrowly focused on derivatives with particular substitutions, reducing overlap with broader prior art.
- The patent landscape includes related patents in the US, China, and Japan, with a focus on similar chemical classes and therapeutic indications.
- Narrow claims and detailed synthesis methods strengthen validity but require the patent holder to vigilantly monitor for similar filings or potential challenges.
- Commercial exclusivity is maintained until 2034 in the European jurisdiction, provided maintenance fees are paid.
FAQs
What is the primary innovation claimed in EP4233910?
It is a specific chemical derivative with improved therapeutic properties, detailed in the structure and synthesis.
Can competitors develop similar compounds?
Yes, if derivatives differ structurally or are used for different indications, they may avoid infringement.
What is the geographical coverage?
European countries, with patent family members filed in the US, China, and Japan.
How strong is the patent’s defensibility?
Fairly strong due to narrow scope and detailed claims, though challenges based on prior art could be mounted.
When does the patent expire?
Expected expiry in 2043, calculated from the filing date (14 March 2023), assuming standard term.
References
[1] European Patent Register. EP4233910. European Patent Office.
[2] WIPO Patent Scope. Patent family data.
[3] EP Patent Office. Patent prosecution reports and amendments.
